review·Cancer Cell·Oct 10, 2024Closed access

The hallmarks of cancer immune evasion

CGClaudia GalassiTATimothy A. ChanIVIlio VitaleCorresponding authorLGLorenzo GalluzziCorresponding author

Cornell University · Weill Cornell Medicine · +3 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

448
total citations
FWCI
112.53
Percentile
100%
References
454
Citations per year

Authors

4
  • CG
    Claudia Galassi

    Cornell University, Weill Cornell Medicine

  • TA
    Timothy A. Chan

    Cleveland Clinic

  • IV
    Ilio VitaleCorresponding

    Candiolo Cancer Institute

  • LG
    Lorenzo GalluzziCorresponding

    Cornell University, Lander Institute

Topics & keywords

Topics
  • Primary topicCancer Immunotherapy and Biomarkers100%
  • Immunotherapy and Immune Responses100%
  • Phagocytosis and Immune Regulation100%
Keywords
  • Immune system
  • Immunosurveillance
  • Biology
  • Cancer cell
  • Evasion (ethics)
  • Cancer
  • Immunotherapy
  • Effector
No related works found for this paper.

Funding

  • LA
    Leukemia and Lymphoma Society
  • AC
    American-Italian Cancer Foundation
    Award: 223565-01
  • LH
    Luke Heller Tec Pr2 Foundation
  • AI
    Associazione Italiana per la Ricerca sul Cancro
    Award: IG 2022 27685
  • NI
    National Institutes of Health
  • SU
    Stand Up To Cancer
  • WC
    Weill Cornell Medicine
  • NC
    National Cancer Institute
    Award: CA271915